行情

MMSI

MMSI

美好医疗系统
NASDAQ

实时行情|Nasdaq Last Sale

43.80
-0.92
-2.06%
盘后: 44.10 +0.3 +0.68% 16:11 08/03 EDT
开盘
45.03
昨收
44.72
最高
45.28
最低
43.71
成交量
30.34万
成交额
--
52周最高
47.99
52周最低
19.50
市值
24.26亿
市盈率(TTM)
-81.2918
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测MMSI价格均价为51.38,最高价位63.00,最低价为42.00。

EPS

MMSI 新闻

更多
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha · 4天前
Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $51
Raymond James maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and raises the price target from $49 to $51.
Benzinga · 4天前
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 4天前
Merit Medical (MMSI) Tops Q2 Earnings and Revenue Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 933.33% and 13.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 5天前
Merit Medical Reports Results for Quarter Ended June 30, 2020
* Q2 2020 worldwide revenue of $218.4 million, down (14.5)% as reported compared to Q2 2019 * Q2 2020 core revenue on a constant currency basis* down (13.6)% compared to Q2 2019 * Q2 2020 GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2
GlobeNewswire · 5天前
Merit Medical Systems EPS beats by $0.24, beats on revenue
Seeking Alpha · 6天前
Merit Medical Q2 revenues and earnings down due to pandemic disruptions
Seeking Alpha · 6天前
Notable earnings after Wednesday's close
Seeking Alpha · 6天前

所属板块

医疗设备、用品及经销
+0.78%
医疗设备和用品
+1.20%

热门股票

代码
价格
涨跌幅

MMSI 简况

Merit Medical Systems, Inc.设计、开发、生产和销售用于一系列介入和诊断流程的医疗设备。该公司通过两个业务部门运营:心血管部和内镜检查术部。其心血管部门提供心脏病学和放射学设备、膀胱治疗产品以及心律管理和电生理学(CRM / EP)设备。心脏病学和放射学设备用于诊断和治疗冠状动脉疾病、外周血管疾病和其他非血管疾病。其内窥镜部门提供胃肠病学和肺部医学设备,用于治疗由恶性肿瘤引起的食管扩张、气管支气管疾病和胆道狭窄。其产品用于各种临床领域,如诊断和介入心脏病学、介入放射学、血管、一般和胸部手术、介入性肺病学、介入肾脏病学、肿瘤学和疼痛管理。
展开

微牛提供Merit Medical Systems, Inc.(NASDAQ-MMSI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的MMSI股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MMSI股票基本功能。